Mutations leading to constitutive activation of the pathway Ras/Raf/MEK/ERK are highly prevalent in hematological cancers and mediates mitogenic and anti-apoptotic signals in leukemia cells [44], [45]. This evidence concerns the gene MAP2K7 and hematopoietic and lymphoid cell neoplasm.